Futibatinib Yields Clinical Benefit in FGFR2+ Intrahepatic Cholangiocarcinoma
February 05, 2023

According to findings from a phase 2 clinical study, futibatinib may achieve benefit in patients with intrahepatic cholangiocarcinoma harboring FGFR2¬ rearrangements.

Pembrolizumab/Chemo Boosts PFS in Advanced/Recurrent Endometrial Cancer
February 05, 2023

Pembrolizumab plus chemotherapy appears to produce a significant improvement in progression-free survival among patients with advanced or recurrent endometrial cancer.

From Clinical Trials to Real-World Practice, Experts Examine the Best Options for TNBC
February 04, 2023

During a live Tweet Chat, Hope S. Rugo, MD, and Paolo Tarantino, MD, reviewed a patient case and discussed current standard of care for those with metastatic triple-negative breast cancer.

Recap: Review of Molecular Testing Options in Metastatic Colorectal Cancer
February 04, 2023

Expert oncologists review key updates regarding metastatic colorectal cancer from recent meetings and discuss their implications on real-world clinical practice.

Expert Emphasizes Importance Cancer Prevention and Screenings and on World Cancer Day
February 03, 2023

An expert from Ochsner Health discusses the essential role positive lifestyle habits and regular screenings play in preventing cancer diagnoses.

Optimal Selection of Therapy for Patients With Transplant-Eligible NDMM
February 03, 2023

A focused discussion on navigating the treatment armamentarium for patients with transplant-eligible newly diagnosed multiple myeloma.

Patient Case 1: Transplant-Eligible Newly Diagnosed Multiple Myeloma
February 03, 2023

Centering discussion on a patient case of transplant-eligible newly diagnosed multiple myeloma, expert panelists consider optimal workup and management strategies.

Survey Highlights Need for Mental Health Support Throughout Cancer Continuum
February 03, 2023

Lack of access to adequate mental health care affects both patients and survivors of cancer who experience significant mental health burdens, highlighting a need to normalize mental health care for patients, according to a licensed clinical social worker.

Meeting Needs, Dismantling Barriers to Cancer Care: A Patient Advocate Weighs in
February 03, 2023

“Being a patient advocate means not so much putting ourselves in the patient's shoes but asking the right questions to find out what those barriers to care are,” says an oncology survivorship navigator from Sibley Memorial Hospital, Johns Hopkins Medicine.

Sacituzumab Govitecan Approval Gives ‘Meaningful’ Survival in Advanced HR+ Breast Cancer
February 03, 2023

An expert from Dana-Farber Cancer Institute discusses what the approval of sacituzumab govitecan means for patients with advanced hormone receptor–positive, HER2-negative breast cancer.